Form 4: Phreesia Director Michael Weintraub Granted 6,700 Restricted Stock Units

Phreesia, Inc. Director Michael Weintraub was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, increasing his beneficial ownership in the company.

Summary

• Michael Weintraub, a Director of Phreesia, Inc. (PHR), acquired 6,700 shares of common stock through a Restricted Stock Unit (RSU) grant on June 25, 2025.
• Each RSU represents the contingent right to receive one share of Phreesia's common stock.
• The RSUs were granted at a price of $27.61 per share.
• These RSUs will vest in full upon the earlier of June 25, 2026, or the next annual meeting of the Issuer's stockholders.
• Following this transaction, Michael Weintraub directly beneficially owns 158,229 shares of common stock.
• Additionally, he indirectly beneficially owns 30,795 shares through the Michael Weintraub 2023 Qualified Annuity Trust and 6,703 shares through the Weintraub Family 2017 Irrevocable Trust.
• The filing was signed by Allison Hoffman, acting as attorney-in-fact for Michael Weintraub, under a Power of Attorney.
• A Substitute Power of Attorney, effective June 23, 2025, appoints Autumn Simpson as a substitute attorney-in-fact for various Phreesia officers and directors, including Michael Weintraub, while not revoking Allison Hoffman's powers.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director's acquisition of shares, even through a grant, generally signals confidence in the company's future and aligns management interests with shareholders. However, it's a routine compensation event, not a discretionary purchase, limiting the positive impact.

Positives

• The acquisition of 6,700 Restricted Stock Units by a director indicates continued alignment of management's interests with those of shareholders, as the value of these units is tied to the company's stock performance.

Future Outlook

The granted Restricted Stock Units are scheduled to vest in full upon the earlier of June 25, 2026, or the date of Phreesia's next annual meeting of stockholders, indicating a future increase in Michael Weintraub's direct shareholdings.

Industry Context

This Form 4 filing represents a routine insider transaction, specifically an equity grant, which is a common component of executive and director compensation packages in the technology and healthcare sectors. Such grants are designed to align the interests of company leadership with long-term shareholder value.

Corporate Governance

Related Party Transactions

• Michael Weintraub indirectly beneficially owns shares through the Michael Weintraub 2023 Qualified Annuity Trust (GRAT), of which he is the trustee and the Weintraub Family 2017 Irrevocable Trust is the beneficiary.
• Michael Weintraub indirectly beneficially owns shares through the Weintraub Family 2017 Irrevocable Trust, whose sole beneficiaries are members of his immediate family.

Stakeholder Impact

• Shareholders: The increase in director ownership, even through an RSU grant, can be viewed positively as it aligns the director's financial interests with the long-term performance of the company, potentially signaling confidence in future growth.

Next Steps

• The granted Restricted Stock Units are expected to vest on or before June 25, 2026, at which point they will convert into shares of Phreesia common stock.

Key Dates

Keywords

Phreesia, PHR, Restricted Stock Units, RSU, Insider Transaction, Form 4, Beneficial Ownership, Director Compensation, Equity Grant, Corporate Governance